Skip to main content

Find Clinical Trials

Home
Conditions
CD22 Positive

Clinical trial condition

CD22 Positive

Explore clinical trials studying CD22 Positive. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

CD22 Positive trial results

Completed

Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML

NCT02311998

Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +21 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details